Cargando…

Association of Basal Hyperglucagonemia with Impaired Glucagon Counterregulation in Type 1 Diabetes

Glucagon counterregulation (GCR) protects against hypoglycemia, but is impaired in type 1 diabetes (T1DM). A model-based analysis of in vivo animal data predicts that the GCR defects are linked to basal hyperglucagonemia. To test this hypothesis we studied the relationship between basal glucagon (Ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farhy, Leon S., Chan, Alice, Breton, Marc D., Anderson, Stacey M., Kovatchev, Boris P., McCall, Anthony L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288769/ https://www.ncbi.nlm.nih.gov/pubmed/22403550 http://dx.doi.org/10.3389/fphys.2012.00040

Ejemplares similares

OR24-4 Targeting Hyperglucagonemia Reverses Glucagon Resistance
por: Bernal-Mizrachi, Ernesto, et al.
Publicado: (2022)

Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hyperglucagonemia
por: Bozadjieva Kramer, Nadejda, et al.
Publicado: (2021)

Role of K(ATP) Channels in Glucose-Regulated Glucagon Secretion and Impaired Counterregulation in Type 2 Diabetes
por: Zhang, Quan, et al.
Publicado: (2013)

Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats
por: Karimian, Negar, et al.
Publicado: (2013)

A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia
por: Amano, Shogo, et al.
Publicado: (2023)

Time-dependent effects of endogenous hyperglucagonemia on glucose homeostasis and hepatic glucagon action
por: Lubaczeuski, Camila, et al.
Publicado: (2023)

Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation
por: Larger, Etienne, et al.
Publicado: (2016)

Opioid Receptor Activation Impairs Hypoglycemic Counterregulation in Humans
por: Carey, Michelle, et al.
Publicado: (2017)

Pathways of Glucagon Secretion and Trafficking in the Pancreatic Alpha Cell: Novel Pathways, Proteins, and Targets for Hyperglucagonemia
por: Asadi, Farzad, et al.
Publicado: (2021)

Increased GABAergic Output in the Ventromedial Hypothalamus Contributes to Impaired Hypoglycemic Counterregulation in Diabetic Rats
por: Chan, Owen, et al.
Publicado: (2011)

Pseudo‐hyperglucagonemia was observed in pancreatectomized patients when measured by glucagon sandwich enzyme‐linked immunosorbent assay
por: Kobayashi, Masaki, et al.
Publicado: (2020)

Ventromedial Hypothalamic Nitric Oxide Production Is Necessary for Hypoglycemia Detection and Counterregulation
por: Fioramonti, Xavier, et al.
Publicado: (2010)

Counterregulation of cAMP-directed kinase activities controls ciliogenesis
por: Porpora, Monia, et al.
Publicado: (2018)

BAFF and APRIL counterregulate susceptibility to inflammation-induced preterm birth
por: Doll, Jessica R., et al.
Publicado: (2023)

Partial Inhibition of Insulin Secretion Results in Glucose Intolerance but Not Hyperglucagonemia
por: Ramanathan, Ranjani P., et al.
Publicado: (2011)

Hyperglucagonemia in Pediatric Adiposity Associates With Cardiometabolic Risk Factors but Not Hyperglycemia
por: Stinson, Sara E, et al.
Publicado: (2022)

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease
por: Maruszczak, Katharina, et al.
Publicado: (2022)

Restoration of Glucose Counterregulation by Islet Transplantation in Long-standing Type 1 Diabetes
por: Rickels, Michael R., et al.
Publicado: (2015)

Hyperglucagonemia in an animal model of insulin- deficient diabetes: what therapy can improve it?
por: Barbetti, Fabrizio, et al.
Publicado: (2016)

Glucagon secretion and signaling in the development of diabetes
por: Gaisano, Herbert Y., et al.
Publicado: (2012)

Automated Insulin Delivery with SGLT2i Combination Therapy in Type 1 Diabetes
por: Garcia-Tirado, Jose, et al.
Publicado: (2022)

Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia
por: Meek, Thomas H., et al.
Publicado: (2015)

In silico Models of Alcohol Dependence and Treatment
por: Kovatchev, Boris, et al.
Publicado: (2012)

One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology
por: Breton, Marc D., et al.
Publicado: (2021)

Effects of Acute Hyperglucagonemia on Hepatic and Intestinal Lipoprotein Production and Clearance in Healthy Humans
por: Xiao, Changting, et al.
Publicado: (2011)

Glucagon Receptor Signaling and Lipid Metabolism
por: Galsgaard, Katrine D., et al.
Publicado: (2019)

Hypoglycemia-Sensing Neurons of the Ventromedial Hypothalamus Require AMPK-Induced Txn2 Expression but Are Dispensable for Physiological Counterregulation
por: Quenneville, Simon, et al.
Publicado: (2020)

12/15-Lipoxygenase Is an Interleukin-13 and Interferon-γ Counterregulated-Mediator of Allergic Airway Inflammation
por: Lindley, Alexa R., et al.
Publicado: (2010)

Regulatory T Cells and IL-10 Independently Counterregulate Cytotoxic T Lymphocyte Responses Induced by Transcutaneous Immunization
por: Stein, Pamela, et al.
Publicado: (2011)

Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme‐linked immunosorbent assay
por: Matsuo, Toshihiro, et al.
Publicado: (2015)

Intra-islet glucagon secretion and action in the regulation of glucose homeostasis
por: Wang, Qinghua, et al.
Publicado: (2013)

The Glucagon-Like Adipokinetic Hormone in Drosophila melanogaster – Biosynthesis and Secretion
por: Hughson, Bryon N.
Publicado: (2021)

Phosphoprotein phosphatase-2A docks to Dishevelled and counterregulates Wnt3a/β-catenin signaling
por: Yokoyama, Noriko, et al.
Publicado: (2007)

The potential of glucagon-like peptide-1 receptor agonists in heart failure
por: Kreiner, Frederik Flindt, et al.
Publicado: (2022)

Abnormal CFTR Affects Glucagon Production by Islet α Cells in Cystic Fibrosis and Polycystic Ovarian Syndrome
por: Huang, Wen Qing, et al.
Publicado: (2017)

Unraveling age-related impairment of the neuromuscular system: exploring biomechanical and neurophysiological perspectives
por: Nùñez-Lisboa, M., et al.
Publicado: (2023)

Philip E. Cryer, MD: Seminal Contributions to the Understanding of Hypoglycemia and Glucose Counterregulation and the Discovery of HAAF (Cryer Syndrome)
por: Dagogo-Jack, Samuel
Publicado: (2015)

Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
por: Kovatchev, Boris, et al.
Publicado: (2020)

A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment
por: Subramanian, Vijaya, et al.
Publicado: (2022)

Muscle-Specific Sensitivity to Voluntary Physical Activity and Detraining
por: Hyatt, Jon-Philippe K., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1jat8gfesfps22fjj39bqe0tht